fluorodeoxyglucose f18 has been researched along with gsk 2126458 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, M; Miller, KD; Sledge, GW; Wang, M; Zheng, QH | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and gsk 2126458
| Article | Year |
|---|---|
[11C]GSK2126458 and [18F]GSK2126458, the first radiosynthesis of new potential PET agents for imaging of PI3K and mTOR in cancers.
Topics: Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Molecular Structure; Neoplasms; Phosphatidylinositol 3-Kinases; Positron-Emission Tomography; Pyridazines; Quinolines; Radiopharmaceuticals; Sulfonamides; TOR Serine-Threonine Kinases | 2012 |